The University of Nevada, Reno IRB will conduct reviews of appropriate, external, human subjects research proposals on a fee-based schedule. The infrastructure that supports the IRB is funded by the indirect (F&A) return on expenditures. That cost is not captured when the funding is run outside of the University. The fees are charged to help offset the costs of such operations, including expertise-based protocol reviews, administrative support, technological infrastructure (electronic-based submission systems), educational and training requirements, and other activities of the Human Research Protection Program (HRPP). Note: The University has an agreement for an annual fee for IRB review from Saint Mary's Medical Center, Renown Medical Center and the VA Sierra Nevada Health Care System. These individual fees will not be charged to these entities as it would result in double billing.
External Principal Investigator and IRB Review
When an investigator is not engaged with the University as an employee or student for the purpose of conducting a research project involving human subjects, that project will be considered external and charged a fee regardless of the for-profit or non-profit nature of the project, investigator, or investigator's company or agency.
The IRB will only conduct external reviews of proposals for which it is qualified in terms of adequate experience and subject expertise. Specifically, the IRB reserves the right to accept or decline a request for review on a case-by-case basis. In most cases, the IRB authorizes the IRB Chair to make this decision, but accepting or declining review will in some cases be determined by the board. The IRB will review proposals at the full-board, expedited, and exempt levels of review as is appropriate to the complexity and risk level of the proposal.
The fees are assessments of costs associated with study reviews conducted by the IRB and are charges for services rendered. Fees are due and payable upon submission to the IRB for initial, continued, amendment or closure review. Checks are payable to the Board of Regents. Send to University of Nevada, Reno. 1664 N Virginia Street, Mail Code 0331, Reno NV 89577.
Fees are non-negotiable and non-refundable. Because the IRB office commits its resources appropriate to each level of review, fees are due in full from the applicant regardless of subsequent conduct of the study, including disapproval by the IRB or early termination by the investigator or sponsor.
Initial Review of the Research - $2,000
Initial review encompasses the review of the research protocol, qualifications of the investigator, associated consent forms, protocol-related advertisements, questionnaires, screening scripts, and other submitted materials.
Expedited review of initial protocol submission - $300
There will be a one-time fee for the initial review of the research protocol, qualifications of the investigator and staff, and other submitted materials, for studies that meet expedite review categories.
Exempt review of initial protocol submission - $150
There will be a one-time fee for the initial review of the research protocol, qualifications of the investigator and staff, and other submitted materials, for studies that meet exempt review categories.
Continuing Review - $725
The IRB must review ongoing research at least annually and that review must be substantive and at least comparable to the initial review. The protocol is reviewed on an annual basis, or more frequently as directed by the Board.
Modifications/Amendments to Research - $400
Modifications to research such as protocol amendments, revised protocols, updates to consent forms, and new recruitment or retention materials, change of principal investigator or Co-Principal Investigator incur a fee. The change in research fee applies each time Board review and preparation of regulatory documentation is required for a research site.
Important note regarding administrative modifications
There is no charge for administrative modifications (i.e., study personnel changes, or site additions) or submission of reportable events (i.e., unanticipated problems, adverse event/serious adverse event, protocol deviation).